XTL Biopharmaceuticals Ltd. (XTLB)
2.53
-0.25
(-8.99%)
USD |
NASDAQ |
Aug 24, 16:00
2.53
0.00 (0.00%)
After-Hours: 20:00
XTL Biopharmaceuticals Enterprise Value
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 5.571M |
| August 20, 2026 | 5.529M |
| August 19, 2026 | 6.044M |
| August 18, 2026 | 6.636M |
| August 17, 2026 | 5.146M |
| August 14, 2026 | 5.583M |
| August 13, 2026 | 5.619M |
| August 12, 2026 | 5.358M |
| August 11, 2026 | 5.264M |
| August 10, 2026 | 5.784M |
| August 07, 2026 | 5.950M |
| August 06, 2026 | 5.784M |
| August 05, 2026 | 5.737M |
| August 04, 2026 | 5.808M |
| August 03, 2026 | 5.762M |
| July 31, 2026 | 5.666M |
| July 30, 2026 | 5.737M |
| July 29, 2026 | 5.996M |
| July 28, 2026 | 5.997M |
| July 27, 2026 | 5.808M |
| July 24, 2026 | 5.950M |
| July 23, 2026 | 5.855M |
| July 22, 2026 | 5.903M |
| July 21, 2026 | 5.903M |
| July 20, 2026 | 5.832M |
| Date | Value |
|---|---|
| July 17, 2026 | 5.713M |
| July 16, 2026 | 5.690M |
| July 15, 2026 | 5.926M |
| July 14, 2026 | 5.997M |
| July 13, 2026 | 5.808M |
| July 10, 2026 | 5.879M |
| July 09, 2026 | 5.832M |
| July 08, 2026 | 5.855M |
| July 07, 2026 | 6.044M |
| July 06, 2026 | 6.423M |
| July 02, 2026 | 5.382M |
| July 01, 2026 | 4.885M |
| June 30, 2026 | 5.453M |
| June 29, 2026 | 4.578M |
| June 26, 2026 | 4.578M |
| June 25, 2026 | 5.063M |
| June 24, 2026 | 5.591M |
| June 23, 2026 | 5.595M |
| June 22, 2026 | 5.382M |
| June 18, 2026 | 5.004M |
| June 17, 2026 | 4.720M |
| June 16, 2026 | 4.625M |
| June 15, 2026 | 4.436M |
| June 12, 2026 | 4.034M |
| June 11, 2026 | 4.530M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| BioLineRx Ltd. | 8.106M |
| Kamada Ltd. | 428.03M |
| Can-Fite BioPharma Ltd. | -4.518M |
| Galmed Pharmaceuticals Ltd. | -12.02M |
| Revium Recovery, Inc. | -- |